Can Replacing CA125 with HE4 in Risk of Malignancy Indices 1–4 Improve Diagnostic Performance in the Presurgical Assessment of Adnexal Tumors?

por Abdalla, Nabil, Piórkowski, Robert, Stanirowski, Paweł, Cendrowski, Krzysztof, Sawicki, Włodzimierz
Publicado 2017

Assessment of levels of the tumor markers HE4 and CA125 considering staging, grading and histological types of endometrial cancer

por Abdalla, Nabil, Piórkowski, Robert, Stanirowski, Paweł, Słomka, Anna, Cendrowski, Krzysztof, Sawicki, Włodzimierz
Publicado 2016

Analysis of serum level of HE4 and CA125 considering selected risk factors among patients with endometrioid endometrial cancer

por Abdalla, Nabil, Piorkowski, Robert, Slomka, Anna, Kania, Malgorzata, Sawicki, Wlodzimierz, Cendrowski, Krzysztof
Publicado 2017

Does Chemotherapy for Gynecological Malignancies during Pregnancy Cause Fetal Growth Restriction?

por Abdalla, Nabil, Bizoń, Magdalena, Piórkowski, Robert, Stanirowski, Paweł, Cendrowski, Krzysztof, Sawicki, Włodzimierz
Publicado 2017

Can ultrasound be helpful in selecting optimal management methods for pregnancies complicated by placental non-trophpblastic tumors?

por Abdalla, Nabil, Piórkowski, Robert, Stanirowski, Paweł, Pazura, Monika, Cendrowski, Krzysztof, Sawicki, Włodzimierz
Publicado 2017

Does the Risk of Ovarian Malignancy Algorithm Provide Better Diagnostic Performance Than HE4 and CA125 in the Presurgical Differentiation of Adnexal Tumors in Polish Women?

por Abdalla, Nabil, Piorkowski, Robert, Bachanek, Michal, Stanirowski, Pawel, Cendrowski, Krzysztof, Sawicki, Wlodzimierz
Publicado 2018